Mutsuo Yamaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mutsuo Yamaya has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Hidetada Sasaki
Tohoku University School of Medicine
6 shared publications- Hidetada Sasaki
Sendai Tomizawa Hospital Sendai Japan
6 shared publications Hiroyuki Arai
Department of Geriatric Medicine, Tohoku University Hospital
4 shared publications- Hidekazu Nishimura
Virus Research Center, Clinical Research Division, Sendai Medical Center National Hospital Organization Sendai Japan
3 shared publications - Hiroshi Kubo
Ritsumeikan University,Faculty of Science and Engineering,Department of Electronic and Computer Engineering,1-1-1 Noji-Higashi, Kusatsu-shi, Shiga,Japan,525-8577
3 shared publications Kiyohisa Sekizawa
University of Tsukuba
3 shared publications
Latest Publications
- 26 March 2012
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 12 (2) , 352-353
Repetitive pneumonia and wheezing in an elderly patient after radiation therapy
- 26 March 2012
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 12 (2) , 352-353
Repetitive pneumonia and wheezing in an elderly patient after radiation therapy
- 1 April 2007
- Vol. 65 (4) , 734-9
[Treatment and prevention of COPD exacerbation].
Airway inflammation, mucosal edema, epithelial hyperpermeability, mucus secretion and airway smooth muscle contraction induced by airway bacterial, virus infection and exposure to air pollution may be associated with COPD exacerbation. Severity of COPD exacerbation is estimated by blood gas analysis, serum CRP values and the chest radiograph. Patients with COPD exacerbations are recommended to be treated with additional inhalations of beta-2 agonists and anti -cholinergic agents, systemic administered glucocorticosteroids, oxygen inhalation, and, in cases with purulent sputum, antibiotics. Glucocorticosteroids, beta-2 agonists and anti-cholinergic agents reduce the frequency of COPD exacerbation. We reported the inhibitory effects of glucocorticosteroids on rhinovirus infection, the major cause of common colds, and the inhibitory effects of L-carbocisteine and erythromycin on COPD exacerbations and rhinovirus infection.
- 1 April 2007
- Vol. 65 (4) , 734-9
[Treatment and prevention of COPD exacerbation].
Airway inflammation, mucosal edema, epithelial hyperpermeability, mucus secretion and airway smooth muscle contraction induced by airway bacterial, virus infection and exposure to air pollution may be associated with COPD exacerbation. Severity of COPD exacerbation is estimated by blood gas analysis, serum CRP values and the chest radiograph. Patients with COPD exacerbations are recommended to be treated with additional inhalations of beta-2 agonists and anti -cholinergic agents, systemic administered glucocorticosteroids, oxygen inhalation, and, in cases with purulent sputum, antibiotics. Glucocorticosteroids, beta-2 agonists and anti-cholinergic agents reduce the frequency of COPD exacerbation. We reported the inhibitory effects of glucocorticosteroids on rhinovirus infection, the major cause of common colds, and the inhibitory effects of L-carbocisteine and erythromycin on COPD exacerbations and rhinovirus infection.
- Open Access
- 1 March 2007
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (6) , 702-710
Hochu‐ekki‐to inhibits rhinovirus infection in human tracheal epithelial cells
Background and purpose: A traditional Japanese herbal medicine, hochu‐ekki‐to, has been used for the symptomatic treatment of the common cold and to reduce the frequency of colds in patients with chronic obstructive pulmonary disease. However, the inhibitory effects of hochu‐ekki‐to on infection by rhinovirus (RV), the major cause of common colds, have not been studied.Experimental approach: Human tracheal epithelial cells in culture were infected with a major group rhinovirus‐RV14. Virus output and viral RNA were measured along with interleukin (IL)‐1β, IL‐6, IL‐8 and tumor necrosis factor (TNF)‐α), mRNA for intercellular adhesion molecule (ICAM)‐1 and acidic endosomes in cells.Key results: RV14 infection increased virus titers, the content of cytokines in supernatants and RV14 RNA in the cells. Hochu‐ekki‐to decreased virus output, RV14 RNA in the cells, susceptibility to RV infection and supernatant cytokine concentrations after RV14 infection. Hochu‐ekki‐to reduced mRNA for ICAM‐1, the receptor for RV14, the concentration of the soluble form of ICAM‐1 and the number and fluorescence intensity of acidic endosomes in the cells, from which RV RNA enters into the cytoplasm, at RV14 infection. Glycyrrhizin, one of the chemical constituents of hochu‐ekki‐to, reduced supernatant virus titers dose‐dependently.Conclusion and implications: Hochu‐ekki‐to inhibited RV14 infection by decreasing ICAM‐1 and by blocking entry of viral RNA into the cytoplasm from the endosomes, in airway epithelial cells. Glycyrrhizin may be partly responsible for inhibition of RV infection by hochu‐ekki‐to. Hochu‐ekki‐to could modulate airway inflammation by reducing production of cytokines in RV infections.British Journal of Pharmacology (2007) 150, 702–710. doi:10.1038/sj.bjp.0707135
- 1 March 2007
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (6) , 702-710
Open AccessHochu‐ekki‐to inhibits rhinovirus infection in human tracheal epithelial cells
Background and purpose: A traditional Japanese herbal medicine, hochu‐ekki‐to, has been used for the symptomatic treatment of the common cold and to reduce the frequency of colds in patients with chronic obstructive pulmonary disease. However, the inhibitory effects of hochu‐ekki‐to on infection by rhinovirus (RV), the major cause of common colds, have not been studied.Experimental approach: Human tracheal epithelial cells in culture were infected with a major group rhinovirus‐RV14. Virus output and viral RNA were measured along with interleukin (IL)‐1β, IL‐6, IL‐8 and tumor necrosis factor (TNF)‐α), mRNA for intercellular adhesion molecule (ICAM)‐1 and acidic endosomes in cells.Key results: RV14 infection increased virus titers, the content of cytokines in supernatants and RV14 RNA in the cells. Hochu‐ekki‐to decreased virus output, RV14 RNA in the cells, susceptibility to RV infection and supernatant cytokine concentrations after RV14 infection. Hochu‐ekki‐to reduced mRNA for ICAM‐1, the receptor for RV14, the concentration of the soluble form of ICAM‐1 and the number and fluorescence intensity of acidic endosomes in the cells, from which RV RNA enters into the cytoplasm, at RV14 infection. Glycyrrhizin, one of the chemical constituents of hochu‐ekki‐to, reduced supernatant virus titers dose‐dependently.Conclusion and implications: Hochu‐ekki‐to inhibited RV14 infection by decreasing ICAM‐1 and by blocking entry of viral RNA into the cytoplasm from the endosomes, in airway epithelial cells. Glycyrrhizin may be partly responsible for inhibition of RV infection by hochu‐ekki‐to. Hochu‐ekki‐to could modulate airway inflammation by reducing production of cytokines in RV infections.British Journal of Pharmacology (2007) 150, 702–710. doi:10.1038/sj.bjp.0707135
- 31 March 2006
- Published by BMJ in Journal of Medical Genetics
- Vol. 43 (4) , e17
Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism
Background: Oxidative stresses including cigarette smoking are implicated in the pathogenesis of cerebrovascular diseases, which are associated with pneumonia because of frequent aspiration. Haem oxygenase-1 (HO-1) acts in cytoprotection against oxidants, provides anti-inflammatory effects, and inhibits atherogenesis. A (GT)n dinucleotide repeat in the human HO-1 promoter modulates HO-1 gene expression and shows length polymorphism, which is grouped into three classes: class S (Objective: To investigate the correlation between the HO-1 gene polymorphism and development of pneumonia in elderly Japanese. Methods: The length of the (GT)n repeats was analysed in 200 elderly patients with pneumonia and 200 control subjects. The association of the HO-1 gene polymorphism with risk of pneumonia was estimated by logistic regression. Results: The proportion of allele frequencies in class L, and the proportion of genotypic frequencies in the L-allele carriers (L/L, L/M, and L/S), was significantly higher in patients with pneumonia than in controls (20% v 10% in class L, and 34% v 18% in L-allele carriers). After adjustment for potentially confounding factors, both cerebrovascular disorders and HO-1 gene L-allele carriers were significant and independent risk factors for pneumonia. The adjusted odds ratio for L-allele carriers v non-L-allele carrier was 2.1 (95% confidence interval, 1.2 to 3.6). Conclusions: The large size of a (GT)n repeat in the HO-1 gene promoter may be associated with susceptibility to pneumonia in the older Japanese population.
- 31 March 2006
- Published by BMJ in Journal of Medical Genetics
- Vol. 43 (4) , e17
Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism
Background: Oxidative stresses including cigarette smoking are implicated in the pathogenesis of cerebrovascular diseases, which are associated with pneumonia because of frequent aspiration. Haem oxygenase-1 (HO-1) acts in cytoprotection against oxidants, provides anti-inflammatory effects, and inhibits atherogenesis. A (GT)n dinucleotide repeat in the human HO-1 promoter modulates HO-1 gene expression and shows length polymorphism, which is grouped into three classes: class S (Objective: To investigate the correlation between the HO-1 gene polymorphism and development of pneumonia in elderly Japanese. Methods: The length of the (GT)n repeats was analysed in 200 elderly patients with pneumonia and 200 control subjects. The association of the HO-1 gene polymorphism with risk of pneumonia was estimated by logistic regression. Results: The proportion of allele frequencies in class L, and the proportion of genotypic frequencies in the L-allele carriers (L/L, L/M, and L/S), was significantly higher in patients with pneumonia than in controls (20% v 10% in class L, and 34% v 18% in L-allele carriers). After adjustment for potentially confounding factors, both cerebrovascular disorders and HO-1 gene L-allele carriers were significant and independent risk factors for pneumonia. The adjusted odds ratio for L-allele carriers v non-L-allele carrier was 2.1 (95% confidence interval, 1.2 to 3.6). Conclusions: The large size of a (GT)n repeat in the HO-1 gene promoter may be associated with susceptibility to pneumonia in the older Japanese population.
- 2 February 2005
- Published by Springer Nature in Human Genetics
- Vol. 116 (5) , 354-360
Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism
Heme oxygenase-1 (HO-1) acts in cytoprotection against oxidants and aromatic hydrocarbons in cigarette smoke. A (GT) n dinucleotide repeat in the 5′-flanking region of the human HO-1 gene (alias HMOX1) reduces HO-1 inducibility and shows length polymorphism, which is grouped into three classes: class S (HO-1 gene polymorphism and the development of lung adenocarcinoma, we screened 151 Japanese patients with lung adenocarcinoma and 153 control subjects. Patients and control subjects were frequency-matched by age, gender, smoking history and proportion of chronic pulmonary emphysema. The proportion of class L allele frequencies, as well as that of genotypic frequencies in L allele carriers (LL, LM, and LS), were significantly higher in patients with lung adenocarcinoma than those of control subjects. The adjusted odds ratio (OR) for lung adenocarcinoma with class L allele vs non-L allele (M+S) was 1.6 [95% confidence interval (CI) 1.0–2.5, P=0.03] and that with L allele carriers vs. non-L allele carriers was 1.8 (95% CI 1.1–3.0, P=0.02). Furthermore, the risk of lung adenocaricinoma for L allele carriers versus non-L allele carriers was much increased in the group of male smokers (OR=3.3, 95% CI 1.5–7.4, P=0.004). However, in the female non-smokers, the proportion of L allele carriers did not differ between patients and control subjects (OR=0.93, 95% CI 0.4–2.0, P=0.85). These findings suggest that the large size of a (GT) n repeat in the HO-1 gene promoter may be associated with the development of lung adenocarcinoma in Japanese male smokers.
- 2 February 2005
- Published by Springer Nature in Human Genetics
- Vol. 116 (5) , 354-360
Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism
Heme oxygenase-1 (HO-1) acts in cytoprotection against oxidants and aromatic hydrocarbons in cigarette smoke. A (GT) n dinucleotide repeat in the 5′-flanking region of the human HO-1 gene (alias HMOX1) reduces HO-1 inducibility and shows length polymorphism, which is grouped into three classes: class S (HO-1 gene polymorphism and the development of lung adenocarcinoma, we screened 151 Japanese patients with lung adenocarcinoma and 153 control subjects. Patients and control subjects were frequency-matched by age, gender, smoking history and proportion of chronic pulmonary emphysema. The proportion of class L allele frequencies, as well as that of genotypic frequencies in L allele carriers (LL, LM, and LS), were significantly higher in patients with lung adenocarcinoma than those of control subjects. The adjusted odds ratio (OR) for lung adenocarcinoma with class L allele vs non-L allele (M+S) was 1.6 [95% confidence interval (CI) 1.0–2.5, P=0.03] and that with L allele carriers vs. non-L allele carriers was 1.8 (95% CI 1.1–3.0, P=0.02). Furthermore, the risk of lung adenocaricinoma for L allele carriers versus non-L allele carriers was much increased in the group of male smokers (OR=3.3, 95% CI 1.5–7.4, P=0.004). However, in the female non-smokers, the proportion of L allele carriers did not differ between patients and control subjects (OR=0.93, 95% CI 0.4–2.0, P=0.85). These findings suggest that the large size of a (GT) n repeat in the HO-1 gene promoter may be associated with the development of lung adenocarcinoma in Japanese male smokers.
- Open Access
- 1 January 2004
- Published by Elsevier in Allergology International
- Vol. 53 (2) , 37-45
Rhinovirus and airway allergy
- 1 January 2004
- Published by Elsevier in Allergology International
- Vol. 53 (2) , 37-45
Open AccessRhinovirus and airway allergy
- 1 September 2003
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 3 (3) , 172-174
Tube feeding in terminal elderly care
- 1 September 2003
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 3 (3) , 172-174
Tube feeding in terminal elderly care
- 1 June 2003
- Published by SAGE Publications in Viral Immunology
- Vol. 16 (2) , 99-109
Rhinovirus and Asthma
Rhinoviruses (RVs) cause the majority of common colds, which often provoke wheezing in patients with asthma. The precise mechanisms responsible for the RV infection-induced exacerbations of bronchial asthma are still uncertain. However, several reports reveal airway hyperresponsiveness, increases in chemical mediators in airway secretions such as kinin and histamine, and airway inflammation in patients with bronchial asthma after RV infection. RV infection induces an accumulation of inflammatory cells in airway mucosa and submucosa including neutrophils, lymphocytes and eosinophils. RV affects the barrier function of airway epithelial cells, and activates the airway epithelial cells and other cells in the lung to produce pro-inflammatory cytokines, including various kinds of interleukins, GM-CSF and RANTES, and histamine. RV also stimulates the expression of intercellular adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptors in the airway epithelium, receptors for major and minor RVs. On the other hand, RV infection is inhibited by treatment with soluble ICAM-1, and by reduction of ICAM-1 expression in the airway epithelial cells after treatment with erythromycin. Both soluble ICAM-1 and erythromycin were reported to reduce the frequency of common colds. Here, we review the pathogenesis and management of RV infection-induced exacerbation of bronchial asthma.
- 1 June 2003
- Published by SAGE Publications in Viral Immunology
- Vol. 16 (2) , 99-109
Rhinovirus and Asthma
Rhinoviruses (RVs) cause the majority of common colds, which often provoke wheezing in patients with asthma. The precise mechanisms responsible for the RV infection-induced exacerbations of bronchial asthma are still uncertain. However, several reports reveal airway hyperresponsiveness, increases in chemical mediators in airway secretions such as kinin and histamine, and airway inflammation in patients with bronchial asthma after RV infection. RV infection induces an accumulation of inflammatory cells in airway mucosa and submucosa including neutrophils, lymphocytes and eosinophils. RV affects the barrier function of airway epithelial cells, and activates the airway epithelial cells and other cells in the lung to produce pro-inflammatory cytokines, including various kinds of interleukins, GM-CSF and RANTES, and histamine. RV also stimulates the expression of intercellular adhesion molecule-1 (ICAM-1) and low-density lipoprotein receptors in the airway epithelium, receptors for major and minor RVs. On the other hand, RV infection is inhibited by treatment with soluble ICAM-1, and by reduction of ICAM-1 expression in the airway epithelial cells after treatment with erythromycin. Both soluble ICAM-1 and erythromycin were reported to reduce the frequency of common colds. Here, we review the pathogenesis and management of RV infection-induced exacerbation of bronchial asthma.
- 1 February 2003
- p. 141-5
[Common cold (rhinovirus)].